|
Vanderbilt March 2016 |
Appendicitis |
Vanderbilt University Medical Center |
Case, Control |
|
|
|
|
|
appendicitis CHOP eMERGE III |
Appendicitis |
CHOP |
Case, Control |
|
|
|
|
|
Sleep Apnea-Columbia |
Sleep Apnea Phenotype |
Columbia University |
Case Only |
|
|
|
|
|
Validation on 75 RA patients |
Identification of Fibromyalgia Patients in a Rheumatoid Arthritis Cohort |
Vanderbilt University |
Case Only |
|
|
97% |
|
|
Fibromyalgia in Rheumatoid Arthritis-Columbia |
Identification of Fibromyalgia Patients in a Rheumatoid Arthritis Cohort |
Columbia University |
Case Only |
|
|
|
|
|
Healthy Weight-Columbia |
MidSouth CDRN - Healthy Weight Algorithm |
Columbia University |
Case Only |
|
|
|
|
|
CHOP Part I |
Epilepsy/Antiepileptic drug response algorithm |
CHOP |
Case, Control |
|
|
92% |
|
|
CHOP Part II- NONRESPONDERS |
Epilepsy/Antiepileptic drug response algorithm |
CHOP |
Case Only |
|
|
85% |
|
|
CHOP Part II- RESPONDERS |
Epilepsy/Antiepileptic drug response algorithm |
|
Case Only |
|
|
85% |
|
|
CCHMC - PART 1 |
Epilepsy/Antiepileptic drug response algorithm |
Cincinnati Children's Hospital Medical Center |
Case Only |
129 |
|
86% |
|
|
Epilepsy Part I - Columbia |
Epilepsy/Antiepileptic drug response algorithm |
Columbia University |
Case, Control |
2 |
244 |
|
|
|
Geisinger Implementation |
Epilepsy/Antiepileptic drug response algorithm |
Geisinger |
Case, Control |
61 |
6,414 |
|
|
|
Epilepsy Phenotype Case and Control |
Epilepsy/Antiepileptic drug response algorithm |
KPWHRI |
Case, Control |
23 |
3,282 |
|
|
|
Harvard CRC Implementation |
Colorectal Cancer (CRC) |
Harvard Medical School |
Case, Control |
95 |
10,388 |
|
|
|
Geisinger Impl |
Colorectal Cancer (CRC) |
Geisinger |
Case, Control |
25 |
25 |
100%, 100% |
|
|
VUMC implementation |
Colorectal Cancer (CRC) |
Vanderbilt University Medical Center |
Case, Control |
|
|
|
|
|
CRC implementation-Columbia |
Colorectal Cancer (CRC) |
Columbia University |
Case, Control |
1 |
2,789 |
|
|
|
NU GWAS CRC cases and controls |
Colorectal Cancer (CRC) |
Northwestern University |
Case, Control |
|
|
|
|
|
Mayo Clinic CRC implicataion |
Colorectal Cancer (CRC) |
Mayo Clinic |
Case, Control |
|
|
|
|
|
NU eMERGEseq CRC cases and controls |
Colorectal Cancer (CRC) |
Northwestern University |
Case, Control |
|
|
|
|
|
Marshfield CRC Implementation |
Colorectal Cancer (CRC) |
Marshfield Clinic Research Institute |
Case Only |
|
|
|
|
|
KPWA/UW (primary site) implementation |
Colorectal Cancer (CRC) |
Group Health and University of Washington |
Case, Control |
|
|
|
|
|
Group Health/University of Washington CRC Validation |
Colorectal Cancer (CRC) |
GH/UW |
Case, Control |
25 |
25 |
92%, 100% |
100%, 100% |
|
Northwestern University Validation |
Colorectal Cancer (CRC) |
Northwestern University |
Case, Control |
50 |
50 |
86%, 98% |
92% |
|
CRS merged all sites |
CRS (Chronic Rhinosinusitis) |
|
Case, Control |
|
|
|
|
